Pharmafile Logo
Pharmafocus logo
Advanced Search

telormedix

Showing 1 posts of 1 posts found.

Phillipe Lutz joins Telormedix

May 13, 2010
Research and Development appointment, research and development, telormedix

Swiss clinical stage biopharmaceutical company Telormedix has appointed Phillipe Lutz chief financial officer. He joins the company from Synosia Therapeutics, …

Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025